Cargando…
Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo‐controlled studies of varenicline
AIMS/INTRODUCTION: Stopping smoking deserves high priority in preventing complications of diabetes; however, only sparse data are available regarding the efficacy of pharmacotherapy in smokers with diabetes. We assessed the efficacy and safety of varenicline in smokers with diabetes who participated...
Autores principales: | Tonstad, Serena, Lawrence, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217903/ https://www.ncbi.nlm.nih.gov/pubmed/27223809 http://dx.doi.org/10.1111/jdi.12543 |
Ejemplares similares
-
Retreatment With Varenicline for Smoking Cessation in Smokers Who Have Previously Taken Varenicline: A Randomized, Placebo-Controlled Trial
por: Gonzales, D, et al.
Publicado: (2014) -
Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial
por: Fagerström, Karl, et al.
Publicado: (2010) -
Varenicline decreases alcohol consumption in heavy-drinking smokers
por: Mitchell, Jennifer M., et al.
Publicado: (2012) -
Clinical utility of varenicline for smokers with medical and psychiatric comorbidity
por: Ebbert, Jon O, et al.
Publicado: (2009) -
Could APO-varenicline and cytisine be solutions for the shortage of varenicline in Brazil?
por: Corrêa, Paulo César Rodrigues Pinto, et al.
Publicado: (2023)